Table 3.
Unadjusted Prevalence and Severity for at Least One Symptom by Patient Characteristics
| N=5422 | Patient Characteristics | Any Symptom | Any Moderate to Severe Symptom | ||
|---|---|---|---|---|---|
| N (%) | % | P-value | % | P-value | |
| Gender | |||||
| Male | 2888 (53.3%) | 92.6% | 47.5% | ||
| Female | 2534 (46.7%) | 94.5% | 0.004 | 54.4% | <0.001 |
| Age (yrs) | |||||
| 21–59 | 1840 (33.9%) | 95.7% | 55.0% | ||
| 60–69 | 1584 (29.2%) | 93.1% | 51.6% | ||
| 70–79 | 1424 (26.3%) | 91.4% | 47.8% | ||
| 80+ | 574 (10.6%) | 92.3% | <0.001 | 42.0% | <0.001 |
| Race | |||||
| White | 3870 (69.7%) | 93.3% | 50.9% | ||
| Hispanic or Latino | 371 (6.8%) | 93.5% | 55.0% | ||
| African American | 726 (13.4%) | 94.8% | 51.7% | ||
| Other | 545 (10.1%) | 93.0% | 0.48 | 45.3% | 0.02 |
| Education | |||||
| Less than high school | 919 (16.9%) | 94.5% | 56.7% | ||
| High school/some college | 3153 (58.2%) | 94.2% | 52.9% | ||
| College degree or more | 1343 (24.8%) | 91.0% | <0.001 | 41.7% | <0.001 |
| (Missing) | 7 (0.1%) | ||||
| Insurance status | |||||
| VA | 634 (11.7%) | 94.2% | 60.7% | ||
| Private | 1910 (35.2%) | 94.2% | 48.7% | ||
| Supplemental | 1996 (36.8%) | 92.1% | 46.7% | ||
| Public | 622 (11.5%) | 93.1% | 56.6% | ||
| None | 214 (3.9%) | 97.7% | 0.007 | 57.0% | <0.001 |
| (Missing) | 46 (0.8%) | ||||
| Wealth (how much money saved to live at current cost of living) | |||||
| < 1 month | 1034 (19.1%) | 96.4% | 63.7% | ||
| 1–2 months | 568 (10.5%) | 96.3% | 62.3% | ||
| 3–6 months | 574 (10.6%) | 95.1% | 51.6% | ||
| 7–12 months | 359 (6.6%) | 95.5% | 49.0% | ||
| More than one year | 2019 (37.2%) | 90.7% | <0.001 | 42.1% | <0.001 |
| (Missing) | 868 (16.0%) | ||||
| Marital Status | |||||
| Not married | 2259 (41.7%) | 94.7% | 56.2% | ||
| Married | 3160 (58.3%) | 92.6% | 0.001 | 46.8% | <0.001 |
| (Missing) | 3 (0.1%) | ||||
| Cancer Type | |||||
| Lung | 2411 (44.5%) | 98.4% | 69.3% | ||
| Colorectal | 3011 (55.5%) | 89.5% | <0.001 | 35.9% | <0.001 |
| Stage | |||||
| Early | 3721 (68.6%) | 92.0% | 45.4% | ||
| Late | 1701 (31.4%) | 96.7% | <0.001 | 62.3% | <0.001 |
| Surgery in last 6 weeks | |||||
| Not received | 5204 (96.0%) | 93.4% | 50.4% | ||
| Received | 218 (4.0%) | 95.0% | 0.36 | 59.6% | 0.007 |
| Radiation in last 6 weeks | |||||
| Not received | 4808 (88.7%) | 92.8% | 47.9% | ||
| Received | 614 (11.3%) | 98.7% | <0.001 | 73.3% | <0.001 |
| Chemotherapy in last 6 weeks | |||||
| Not received | 3085 (56.9%) | 90.4% | 45.1% | ||
| Received | 2337 (43.1%) | 97.4% | <0.001 | 58.2% | <0.001 |
| Comorbidity | |||||
| 0–1 | 3286 (60.6%) | 91.7% | 42.9% | ||
| 2+ | 2125 (39.2%) | 96.2% | <0.001 | 62.8% | <0.001 |
| (Missing) | 11 (0.2%) | ||||